Potential impact of COVID-19 pandemic on escalating antimicrobial resistance in Pakistan.
作者信息
Rana Muhammad Suleman, Usman Muhammad, Salman Muhammad, Alam Muhammad Masroor, Ikram Aamer, Umair Massab, Faryal Rani, Anas Muhammad, Qadir Mehmood
机构信息
National Institute of Health Islamabad, Pakistan.
National Institute of Health Islamabad, Pakistan.
出版信息
J Infect. 2021 Sep;83(3):e12-e13. doi: 10.1016/j.jinf.2021.07.024. Epub 2021 Jul 28.
Abstract
摘要
相似文献
1
Potential impact of COVID-19 pandemic on escalating antimicrobial resistance in Pakistan.新冠疫情对巴基斯坦抗菌药物耐药性不断升级的潜在影响。
J Infect. 2021 Sep;83(3):e12-e13. doi: 10.1016/j.jinf.2021.07.024. Epub 2021 Jul 28.
2
Has There Been Exacerbation of Disparities in Antimicrobial Resistance during the SARS-Cov-2 Pandemic?在新冠疫情期间，抗菌药物耐药性的差异是否加剧了？
Surg Infect (Larchmt). 2022 Sep;23(7):613-615. doi: 10.1089/sur.2022.099. Epub 2022 Jul 28.
3
Combating antimicrobial resistance during the COVID-19 pandemic.在新冠疫情期间对抗抗菌药物耐药性
Hong Kong Med J. 2021 Dec;27(6):396-398. doi: 10.12809/hkmj215124. Epub 2021 Nov 17.
4
Antimicrobial resistance vs COVID-19: A bigger challenge in the post-pandemic era!抗微生物药物耐药性与新冠疫情：大流行后时代的一项更大挑战！
J Formos Med Assoc. 2021 Jul;120(7):1537-1538. doi: 10.1016/j.jfma.2021.03.003. Epub 2021 Mar 14.
5
Antimicrobial resistance research in a post-pandemic world: Insights on antimicrobial resistance research in the COVID-19 pandemic.大流行后世界的抗菌药物耐药性研究：关于新冠疫情中抗菌药物耐药性研究的见解
J Glob Antimicrob Resist. 2021 Jun;25:5-7. doi: 10.1016/j.jgar.2021.02.013. Epub 2021 Mar 1.
6
Antimicrobial resistance and the COVID-19 pandemic.抗菌药物耐药性与新冠疫情
Bull World Health Organ. 2022 May 1;100(5):295-295A. doi: 10.2471/BLT.21.287752.
7
Coronavirus Disease 2019 and Antimicrobial Resistance: Parallel and Interacting Health Emergencies.2019 年冠状病毒病与抗菌药物耐药性：平行且相互作用的健康紧急事件。
Clin Infect Dis. 2021 May 4;72(9):1657-1659. doi: 10.1093/cid/ciaa773.
8
Could the COVID-19 pandemic aggravate antimicrobial resistance?新冠疫情会加剧抗菌药物耐药性吗？
Am J Infect Control. 2020 Sep;48(9):1129-1130. doi: 10.1016/j.ajic.2020.06.192. Epub 2020 Jun 27.
9
Antimicrobial stewardship challenges and innovative initiatives in the acute hospital setting during the COVID-19 pandemic.新冠疫情期间急症医院环境中的抗菌药物管理挑战与创新举措
J Antimicrob Chemother. 2021 Jan 1;76(1):272-275. doi: 10.1093/jac/dkaa400.
10
COVID-19 and potential aggravation of antimicrobial resistance in Pakistan.2019冠状病毒病与巴基斯坦抗菌药物耐药性的潜在加剧
J Pak Med Assoc. 2023 Jan;73(1):208. doi: 10.47391/JPMA.6410.
引用本文的文献
1
Paediatricians' knowledge, perceptions, preparedness and involvement towards paediatric antimicrobial stewardship in Pakistan: findings and the implications.巴基斯坦儿科医生关于儿童抗菌药物管理的知识、认知、准备情况及参与度：研究结果与启示
JAC Antimicrob Resist. 2024 Dec 9;6(6):dlae193. doi: 10.1093/jacamr/dlae193. eCollection 2024 Dec.
2
Antibiotic resistance and the COVID-19 pandemic: A dual crisis with complex challenges in LMICs.抗生素耐药性与新冠疫情：低收入和中等收入国家面临的双重危机及复杂挑战
Health Sci Rep. 2023 Sep 13;6(9):e1566. doi: 10.1002/hsr2.1566. eCollection 2023 Sep.
3
A Systematic Review of Antimicrobial Resistance During the COVID-19 Pandemic.COVID-19 大流行期间的抗菌药物耐药性系统评价
Hawaii J Health Soc Welf. 2023 Aug;82(8):188-193.
4
How Universal Health Coverage can curb the escalating antimicrobial resistance in Pakistan: a call to action for the country's healthcare system.全民健康覆盖如何遏制巴基斯坦日益严重的抗菌药物耐药性：呼吁该国医疗系统采取行动
Trop Med Health. 2022 Nov 14;50(1):86. doi: 10.1186/s41182-022-00478-5.
5
Multifunctional Derivatives of Spiropyrrolidine Tethered Indeno-Quinoxaline Heterocyclic Hybrids as Potent Antimicrobial, Antioxidant and Antidiabetic Agents: Design, Synthesis, In Vitro and In Silico Approaches.螺吡咯烷稠合茚并喹喔啉杂环杂合体的多功能衍生物作为有效的抗菌、抗氧化和抗糖尿病药物：设计、合成、体外和计算方法。
Molecules. 2022 Oct 25;27(21):7248. doi: 10.3390/molecules27217248.
6
Exploring Knowledge of Antibiotic Use, Resistance, and Stewardship Programs among Pharmacy Technicians Serving in Ambulatory Care Settings in Pakistan and the Implications.探索巴基斯坦门诊护理机构中工作的药剂师技术员对抗生素使用、耐药性及管理计划的了解情况及其影响。
Antibiotics (Basel). 2022 Jul 8;11(7):921. doi: 10.3390/antibiotics11070921.
7
A Patient With Fever, Loose Motions and Jaundice: Hickam's Dictum or Occam's Razor.一位伴有发热、腹泻和黄疸的患者：希卡姆格言还是奥卡姆剃刀原则
Cureus. 2022 Mar 18;14(3):e23295. doi: 10.7759/cureus.23295. eCollection 2022 Mar.
8
Co-infections and antimicrobial use among hospitalized COVID-19 patients in Punjab, Pakistan: findings from a multicenter, point prevalence survey.巴基斯坦旁遮普邦住院 COVID-19 患者的合并感染和抗菌药物使用情况：一项多中心、时点患病率调查的结果。
Pathog Glob Health. 2022 Oct;116(7):421-427. doi: 10.1080/20477724.2021.1999716. Epub 2021 Nov 16.
本文引用的文献
1
An Overview of the Treatment Options Used for the Management of COVID-19 in Pakistan: Retrospective Observational Study.《巴基斯坦 COVID-19 管理中使用的治疗方法概述：回顾性观察研究》
JMIR Public Health Surveill. 2021 May 27;7(5):e28594. doi: 10.2196/28594.
2
Underestimation of co-infections in COVID-19 due to non-discriminatory use of antibiotics.由于抗生素的非特异性使用导致对新冠病毒感染合并感染的低估。
J Infect. 2020 Sep;81(3):e29-e30. doi: 10.1016/j.jinf.2020.06.077. Epub 2020 Jul 3.
3
Over-the-counter medicines in Pakistan: misuse and overuse.巴基斯坦的非处方药：误用与滥用。
Lancet. 2020 Jan 11;395(10218):116. doi: 10.1016/S0140-6736(19)32999-X.
Zotero 插件